Cancer HealthCast: This AI Tool Could Predict a Patient’s Response to Immunotherapy
NCI cancer researcher highlights how AI is playing a pivotal role in cancer care.
Artificial intelligence is impacting two main areas of cancer research: image analysis and managing massive amounts of clinical data. The National Cancer Institute sees AI as a key capability in precision oncology.
Dr. Eytan Ruppin, chief of NCI’s Cancer Data Science Lab, recently published a study about a new AI tool researchers are implementing to foresee how a patient will respond to immunotherapy by providing an in-depth look at the clinical characteristics of the patient as well as the Tumor Mutational Burden (TMB).
Ruppin discusses the NCI/CCR Synthesis Clinical Trial expected to start this fall and shares details about how the research will impact the treatment of aggressive breast cancer.
-
Dr. Eytan Ruppin Chief, Cancer Data Science Lab NCI
-
DHS Tabs Cyber and AI as Innovation R&D Priorities
Homeland Security leaders ranked cybersecurity and AI as its top two priorities for its research and development strategy.
5m read -
VA Rolls Out Tele-emergency Care Program Nationwide
The Department of Veterans Affairs announced the roll out of its tele-emergency care program nationwide this week.
4m read -
Congress Prioritizes AI, Modernization in Defense Funding Bill
Drafts of the National Defense Authorization Act include provisions on emerging technology, AI governance and zero trust.
5m read -
DHA Official: Optimization is 'Future' of Federal EHR
Defense Healthcare Management Systems Program Officer Dr. Yvette Weber says usable information across health systems is key to clinical care.
5m read
